SI1053027T1 - Bibapcitide-based pharmaceutical compositions for imaging and treating thrombi - Google Patents

Bibapcitide-based pharmaceutical compositions for imaging and treating thrombi

Info

Publication number
SI1053027T1
SI1053027T1 SI9930708T SI9930708T SI1053027T1 SI 1053027 T1 SI1053027 T1 SI 1053027T1 SI 9930708 T SI9930708 T SI 9930708T SI 9930708 T SI9930708 T SI 9930708T SI 1053027 T1 SI1053027 T1 SI 1053027T1
Authority
SI
Slovenia
Prior art keywords
bibapcitide
imaging
pharmaceutical compositions
based pharmaceutical
treating thrombi
Prior art date
Application number
SI9930708T
Other languages
English (en)
Slovenian (sl)
Inventor
Richard T. Dean
John Lister-James
Original Assignee
Diatide, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9802681A external-priority patent/GB9802681D0/en
Application filed by Diatide, Inc. filed Critical Diatide, Inc.
Publication of SI1053027T1 publication Critical patent/SI1053027T1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SI9930708T 1998-02-06 1999-02-05 Bibapcitide-based pharmaceutical compositions for imaging and treating thrombi SI1053027T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/020,086 US6028056A (en) 1998-02-06 1998-02-06 Pharmaceutical compositions for imaging and treating thrombi
GB9802681A GB9802681D0 (en) 1998-02-06 1998-02-06 Pharmaceutical compoations for imaging and treating thrombi
EP99906771A EP1053027B1 (en) 1998-02-06 1999-02-05 Bibapcitide-based pharmaceutical compositions for imaging and treating thrombi
PCT/US1999/002583 WO1999039747A1 (en) 1998-02-06 1999-02-05 Bipapcitide-based pharmaceutical compositions for imaging and treating thrombi

Publications (1)

Publication Number Publication Date
SI1053027T1 true SI1053027T1 (en) 2005-04-30

Family

ID=26313082

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930708T SI1053027T1 (en) 1998-02-06 1999-02-05 Bibapcitide-based pharmaceutical compositions for imaging and treating thrombi

Country Status (26)

Country Link
US (1) US6028056A (ja)
EP (1) EP1053027B1 (ja)
JP (1) JP2003532617A (ja)
KR (1) KR100452390B1 (ja)
CN (1) CN1103606C (ja)
AR (1) AR018546A1 (ja)
AT (1) ATE279214T1 (ja)
AU (1) AU761778B2 (ja)
BR (1) BR9908352A (ja)
CA (1) CA2319544C (ja)
DE (1) DE69921096T2 (ja)
DK (1) DK1053027T3 (ja)
EA (1) EA005406B1 (ja)
ES (1) ES2229681T3 (ja)
HK (1) HK1032198A1 (ja)
HU (1) HUP0100887A3 (ja)
IL (1) IL137076A (ja)
NO (1) NO20003881L (ja)
NZ (1) NZ505085A (ja)
PE (1) PE20000250A1 (ja)
PL (1) PL342253A1 (ja)
PT (1) PT1053027E (ja)
SI (1) SI1053027T1 (ja)
SK (1) SK284463B6 (ja)
TW (1) TWI246425B (ja)
WO (1) WO1999039747A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY174617A (en) 2011-08-17 2020-05-01 Life Molecular Imaging Sa Compounds for binding to the platelet specific glycoprotein iib/iiia and their use for imaging of thrombi
US20160008490A1 (en) 2013-02-12 2016-01-14 Bayer Pharma Aktiengesellschaft Metal chelate compounds for binding to the platelet specific glycoprotein iib/iiia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830856A (en) * 1991-02-08 1998-11-03 Diatide, Inc. Radiolabeled compounds for thrombus imaging
US5645815A (en) * 1991-02-08 1997-07-08 Diatide, Inc. Radiolabled compounds for thrombus imaging
US5508020A (en) * 1992-06-05 1996-04-16 Diatech, Inc. Technetium-99M labeled peptides for imaging
DK0641222T3 (da) * 1992-05-21 2000-12-11 Diatide Inc Peptider mærket med technetium-99m til trombeafbildning

Also Published As

Publication number Publication date
BR9908352A (pt) 2000-11-28
EP1053027A1 (en) 2000-11-22
KR100452390B1 (ko) 2004-10-08
WO1999039747A1 (en) 1999-08-12
HK1032198A1 (en) 2001-07-13
KR20010040676A (ko) 2001-05-15
AU2660499A (en) 1999-08-23
AR018546A1 (es) 2001-11-28
DE69921096T2 (de) 2006-02-02
IL137076A0 (en) 2001-06-14
NZ505085A (en) 2002-10-25
PT1053027E (pt) 2005-01-31
AU761778B2 (en) 2003-06-12
DK1053027T3 (da) 2005-01-17
NO20003881D0 (no) 2000-07-28
HUP0100887A3 (en) 2003-08-28
EA005406B1 (ru) 2005-02-24
CA2319544C (en) 2006-07-04
CN1290179A (zh) 2001-04-04
US6028056A (en) 2000-02-22
TWI246425B (en) 2006-01-01
EA200000820A1 (ru) 2001-02-26
CA2319544A1 (en) 1999-08-12
JP2003532617A (ja) 2003-11-05
IL137076A (en) 2004-08-31
PL342253A1 (en) 2001-06-04
SK284463B6 (sk) 2005-04-01
CN1103606C (zh) 2003-03-26
DE69921096D1 (de) 2004-11-18
ATE279214T1 (de) 2004-10-15
ES2229681T3 (es) 2005-04-16
SK11392000A3 (sk) 2001-03-12
NO20003881L (no) 2000-07-28
HUP0100887A2 (hu) 2001-06-28
PE20000250A1 (es) 2000-06-02
EP1053027B1 (en) 2004-10-13

Similar Documents

Publication Publication Date Title
EP0885199A4 (en) KAPPA AGONIST COMPOUNDS AND PHARMACEUTICAL PREPARATIONS THEREOF
HUP9601419A3 (en) Synergetic pharmaceutical compositions for treating parkinson-disease
SG79255A1 (en) Pharmaceutical formulations
EG24118A (en) Pharmaceutical compositions
ZA988016B (en) Compounds methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
EP1112252A4 (en) KAPPA AGONIST COMPOUNDS AND PHARMACEUTICAL FORMULATIONS THEREOF
EP1061866A4 (en) KNOCHENXENOTRANSPLANTATE
IL139658A0 (en) Pharmaceutical compositions for treatment and prophylaxis and method for their preparation
EP1109548A4 (en) COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING BONE DISEASES USING TOCOTRIENOLE
GB9621570D0 (en) Formulations and methods for inhibiting bone loss
GB9610359D0 (en) Pharmaceutical compositions
IL121096A0 (en) Pharmaceutical compositions for the treatment of liver disease
AU4841799A (en) Methods and pharmaceutical formulations for preventing and treating motion sickness
GB9606429D0 (en) Pharmaceutical compositions
EP0987942A4 (en) PHARMACEUTICAL COMPOSITION AND METHOD OF USE
IL137076A0 (en) Bibapctitide-based pharmaceutical compositions for imaging and treating thrombi
IL136635A0 (en) Pharmaceutical formulations and processes for their preparation
GB9610136D0 (en) Pharmaceutical compositions
GB9802681D0 (en) Pharmaceutical compoations for imaging and treating thrombi
HU9902296D0 (en) Pharmaceutical composition for treating caltification
GB9700220D0 (en) Methods and compositions for preventing and treating bone loss
GB9700293D0 (en) Methods and compositions for preventing and treating bone loss
GB9700221D0 (en) Methods and compositions for preventing and treating bone loss
GB9810540D0 (en) Methods and compositions for preventing and treating bone loss
IL122862A0 (en) Pharmaceutical compositions for treating cytomegalovirus